Last month: The one company with rights over #diabetes#medication in the UK don't produce enough, blames it on its popularity for weight loss.
This month: The one company with rights over #ADHD medication in the UK don't produce enough, blames it on packaging logistics and increase in diagnosis.
In both cases: "It's not our fault", it can't be legally obtained anywhere, lives are damaged or at risk, and the "cost" to the #monopoly is a bit of hand-waving in the press. It's appalling.
Add comment